Skip to main content

Section N in Depth: Medications, the Drug Regimen Review, and the Clock

18 minute read

Section N is where a therapist's job description quietly gets bigger. The manual's own introduction sets the scope: these items record whether the patient is taking any medications in high-risk drug classes, whether there is a patient-specific indication noted and the patient or caregiver has been educated about those medications, whether a drug regimen review was conducted, and whether the patient can manage oral and injectable medications.

On a case with nursing on it, most of that work lands on the nurse. On a therapy only case it lands on you, and the manual says so in its own worked example, where during the comprehensive assessment visit the PT reviews all the patient's medications and identifies no problems except one. That example is not a footnote. It is CMS showing a physical therapist conducting a drug regimen review and coding the item.

Why this matters is written into the item rationale, without hedging. Medication adverse consequences and errors are prevalent among post-acute care settings and often occur during transitions in care, and medication errors can lead to medication-related adverse reactions, emergency department visits, and re-hospitalizations. The medication problem nobody caught at the start of care is one of the shortest paths from a home health admission back to a hospital bed.

The SOC OASIS: Clinical Systems & Functional Scoring section, earlier in this module, already covers the therapist's medication role and what each class of drug means for your session, and the What the Reviewer Flags: Medications callout inside it owns the rule that the oral medication item scores ability rather than adherence. Neither is repeated here. This section is the item-level layer: what each item asks, when it is asked, what the manual's own definitions include and exclude, and where these get coded wrong. Everything below traces to the OASIS-E2 guidance manual (April 2026).

The Section N Items and When They Are Scored

ItemWhat it asksWhen it is scored
N0415 High-risk drug classes: use and indicationWhether the patient takes prescribed medications in the listed drug classes, and whether a patient-specific indication is documented for every medication in the classStart of care, resumption of care, discharge
M2001 Drug regimen reviewWhether a review was conducted, and whether any potential or actual clinically significant medication issues were foundStart of care, resumption of care
M2003 Medication follow-upWhether those issues were communicated and acted on inside the deadlineStart of care, resumption of care
M2005 Medication interventionThe same follow-up question asked across the whole episode instead of at admissionTransfer, death at home, discharge
M2010 Patient/caregiver high-risk drug educationWhether the patient or caregiver was instructed about all the high-risk medications the patient takesStart of care, resumption of care
M2020 Management of oral medicationsThe patient's ability to prepare and take all oral medications reliably and safelyStart of care, resumption of care, discharge
M2030 Management of injectable medicationsThe patient's ability to take all injectable medications safely and reliablyStart of care, resumption of care

The third column repays a second read. The drug regimen review pair, M2001 and M2003, lives only on the admission side. There is no discharge version of them. M2005 is their back-end mirror: at transfer, at death at home, and at discharge it asks the same follow-up question about every issue identified at any point since the most recent start or resumption of care. The oral medication item is scored at discharge; the injectable item is not.

M2001: What a Drug Regimen Review Actually Requires

The manual defines the review before it asks you to code it. A drug regimen review in post-acute care is generally considered to include medication reconciliation, a review of all medications a patient is currently using, and review of the drug regimen to identify, and if possible, prevent potential clinically significant medication issues. Three moves: reconcile, review, and look forward for problems.

Do it as close to the actual time of the start or resumption of care as possible. It covers every medication on the reconciled profile taken by any route, and the manual spells the routes out: oral, topical, sublingual, and by infusion. The inclusion list itself, which reaches well past the prescription bottles, is the one the Section J in Depth: Risk, Falls, Pain, and Breath section, earlier in this module, already lays out for the risk item, and it is not repeated here.

What you are hunting for has a defined shape. The manual's list is not exhaustive, but it is specific.

What a Drug Regimen Review Looks For
Tap a card for the detail

Read the last card twice, because it is where two rules meet. Nonadherence is a drug regimen review issue. It is also, per the reviewer callout named above, not what the oral medication item scores. The same observation goes to two different places on the same assessment: it can make M2001 a yes, and it does not by itself move M2020.

None of it counts until it clears the threshold, and the threshold is a definition rather than a feeling. A potential or actual clinically significant medication issue is one that, in the clinician's professional judgment, warrants physician or allowed practitioner communication and completion of prescribed or recommended actions by midnight of the next calendar day at the latest. The manual then closes the door from the other side: any circumstance that does not require this immediate attention is not considered a potential or actual clinically significant medication issue for these items.

That is why the manual's own therapist example codes the way it does. The newly prescribed pain medication was not in the home, the family had decided to pick it up only if the pain got bad enough, the therapist reviewed the physician's instructions with the patient and the child, and the child went to the drugstore and came back with it before the visit ended.

Coded Code 0, because in the therapist's professional judgment it did not require physician contact by midnight of the next calendar day to resolve. A problem you solved in the home is still a problem you document. It is not automatically a clinically significant medication issue.

The responses:

  • Code 0, no issues found, when a complete review was conducted and, in the assessing clinician's professional judgment, no potential or actual clinically significant issues were identified.
  • Code 1, issues found during review, when a complete review was conducted and such issues were identified.
  • Code 9, not applicable, when the review was conducted and, per the sources reviewed, there were no medications prescribed and the patient was not taking any medications by any route at the time of assessment.
  • A dash, which is valid here, means no information, and CMS expects dash use to be a rare occurrence. On this item it also has a specific job: if elements of the review were skipped, for example the check for drug to drug interactions was not completed, a dash is reported, indicating the drug regimen review was not completed.

That last bullet is the one that changes behavior. A partial review is not a clean review. When any element is not assessed, the review is incomplete and the honest response is a dash.

One more piece of machinery matters on a therapy only case. The comprehensive assessment is the responsibility of and must ultimately be completed by one clinician, but collaboration is allowed, and the manual spells out how that works: the assessing clinician evaluates patient status, for example potential ineffective drug therapy or nonadherence, while another clinician in the office assists with the medication list, for example possible duplicate therapy or omissions.

When any portion is done by staff other than the clinician completing the assessment, those findings must be communicated back to the assessing clinician so the response can be entered. You can get help. You cannot hand off the answer.

M2003 and M2005: Two-Way Communication and a Completed Action

Finding the issue is half the item. M2003 asks whether the issues identified at the start or resumption of care were communicated to the physician, allowed practitioner, or physician-designee, and whether the prescribed or recommended actions were completed, to the extent possible, by midnight of the next calendar day following identification.

The manual states the test as two conditions joined by an AND, and both carry the same deadline.

What M2003 Requires After an Issue Is Found

Two-way is doing a great deal of work in that second row. The manual's own example of a Code 0 is a clinician who communicated every identified issue inside the window but did not receive a response carrying the prescribed or recommended actions until after it. The call going out is not the communication the item is scoring. The loop closing is.

The deadline itself is simpler than clinicians expect. It is the end of the calendar day after the day the issue was identified, and the hour of identification does not change it. An issue found on a morning visit and an issue found late that same evening share one deadline: the end of the next day.

There is an escape hatch, and it is narrow. If the physician recommends an action that will take longer than the window to complete, for example an order to monitor the issue over the next three days and call if the problem persists, Code 1 is still correct as long as by midnight of the next calendar day the agency has taken whatever actions are possible to comply. Otherwise it is Code 0 when the communication and the completed actions fell outside the window and Code 1 when both landed inside it. A dash is valid here too, means no information, and is expected to be rare.

◆Self check
You find a duplicate blood pressure medication on a Monday morning visit and fax the prescriber's office that afternoon. The office calls back Wednesday with an order to stop one of them, and you carry it out that day. How does M2003 code?

M2005 asks the same question at the other end of the episode. At transfer, at death at home, and at discharge, the assessing clinician reviews the clinical record back to and including the most recent start or resumption of care and asks whether, for every clinically significant medication issue identified at any point, the communication happened and the actions were completed by midnight of the next calendar day each time.

Code 9 is the honest not-applicable when no such issues were identified during the episode or the patient was not taking medications. Code 0 covers the episode where any single issue missed the window, and the manual is explicit that one miss is enough, even if every other issue was addressed before the deadline.

N0415: The Classes and the Indication Question

N0415 asks two questions about the same medication list, recorded in two columns. Column 1 asks whether the patient is taking any prescribed medication in the drug class. Column 2 asks whether a patient-specific indication is documented for all medications in that class. The manual defines an indication as the identified, documented clinical rationale for administering a medication that is based upon a physician's or prescriber's assessment of the patient's condition and therapeutic goals.

The second column is where this item gets missed, because it is all or nothing. When a patient takes two medications in the same class and one has a documented rationale while the other does not, Column 1 is checked and Column 2 is not. All medications in the class need the indication documented before that box can be checked, which makes this one of the few OASIS items you can improve with a chart review and a phone call rather than a better assessment.

The rules that decide which line a medication lands on:

  • Code by the medication's therapeutic category or pharmacological classification, regardless of why the patient is taking it. A medication classified as an antipsychotic and an antiemetic is coded as an antipsychotic even when it was prescribed for nausea.
  • Combination medications are coded in every class that constitutes the combination. Percodan, a combination classified as both an opioid and an antiplatelet, has Column 1 checked on both lines regardless of why it was prescribed.
  • Code a medication that is part of the current reconciled drug regimen even if it was not taken on the day of assessment, and include medications used by any route in any setting while the person is a patient of the agency.
  • Include newly prescribed medications that are part of the current regimen even if the medication is not yet in the home and the first dose has not been taken.
  • Long-acting medications given every few weeks or monthly, such as a decanoate injection, count only when they are part of the current reconciled regimen at the time of assessment. Transdermal patches are treated as long-acting medications and are included on the same basis.
  • At discharge the item identifies the medications in the prescribed regimen at discharge, even if not taken that day, and whether they are expected to be taken afterward.
  • Herbal and alternative medicine products are considered dietary supplements by the Food and Drug Administration, so they are not counted as medications for this item.

Three specific traps live on the anticoagulant line. Antiplatelet medications are not coded on N0415E. Flushes given to keep an IV access port patent are not coded there either. Target specific oral anticoagulants, which may or may not require laboratory monitoring, do belong on it. The opioid line is N0415H and the antiplatelet line is N0415I, which is worth knowing the first time a chart review comes back citing a letter instead of a name.

A dash is valid on this item, means no information, and is expected to be rare. CMS also does not name a source for determining a medication's therapeutic category, and does not publish an exhaustive list of what counts as a documented patient-specific indication, which leaves available resources plus clinical judgment, documented.

◆Self check
Your patient takes two antidepressants. The chart carries a documented clinical rationale for one of them and nothing at all for the other. How do you complete the N0415 lines for that class?

M2010, M2020, and M2030: Education, and Ability Again

M2010 identifies whether clinicians instructed the patient or caregiver about all the high-risk medications the patient takes. High risk has a specific meaning here: medications identified by an authoritative source as having considerable potential for causing significant patient harm when they are used erroneously, drawn from the patient's reconciled medication profile. The manual names the Institute for Safe Medication Practices, the American Geriatrics Society, and The Joint Commission as examples of authoritative sources, and its own Appendix E carries the links.

This is a different question from the one above it. N0415 works from the classes printed on the form, while this item works from the medications an authoritative source flags as high risk on this particular profile.

Code 1 when high-risk medications are prescribed and education was provided. Code 0 when the interventions were not completed as the item outlines. Code NA when the patient or caregiver is already fully knowledgeable about the special precautions associated with all the high-risk medications in the profile, or when there are no high-risk drugs in it. A dash is not valid.

The operative word is all, so teaching the patient about the anticoagulant and skipping the rest does not satisfy an item that asks about every high-risk medication. Education delivered by other agency staff can be communicated to the assessing clinician for consideration, and doing so does not violate the requirement that one clinician completes the comprehensive assessment.

M2020 identifies the patient's ability to prepare and take all oral medications reliably and safely on the day of the assessment. The ability rule itself belongs to the reviewer callout named at the top of this section.

What that callout does not carry is the item mechanics, and the mechanics are unusually favorable to a therapist, because the manual's own list of what limits ability reads like a therapy problem list: physical impairments such as limited manual dexterity, emotional, cognitive, or behavioral impairments such as memory deficits, impaired judgment, or fear, sensory impairments such as impaired vision or pain, and environmental barriers such as access to the kitchen or the medication storage area, stairs, and narrow doorways. You assessed every one of those anyway.

Scope first. The item covers all prescribed and over the counter oral medications the patient currently takes that are on the plan of care, and it excludes topical, injectable, and intravenous medications. Oral means placed in the mouth and swallowed, with absorption through the gastrointestinal system, so sublingual, buccal, swish and expectorate, and anything given per gastrostomy or other tube sit outside this item.

Then the task chain, which is what management means here. The assessment covers whether the patient can obtain the medication from where it is routinely stored, read the label or otherwise identify the medication correctly, open the container, select the pill or tablet or the correct milliliters of liquid, and orally ingest it at the correct times. When ability varies from one medication to another, consider the medication for which the most assistance is needed.

◆Self check
Your patient handles her once daily tablet without any help, and the liquid she has to measure into an oral syringe morning and night defeats her every time. Which medication does M2020 score on?

The responses climb by who has to do what:

  • Code 0, able independently, including the patient who sets up their own planner device and takes the right medication in the right dose at the right time as a result.
  • Code 1, able to take the medication correctly, but another person must prepare individual doses in advance, or modify the original container to enable access, or develop a drug diary or chart the patient relies on.
  • Code 2, able if given reminders, when daily reminders are necessary, whether or not the patient is independent at setting up doses. Reminders from a device the patient can independently set up and manage do not count as reminders here.
  • Code 3, unable unless another person administers the medication, when the patient does not have the physical or cognitive ability on the day of assessment to take all medications correctly and every time ordered, and it has not been established that setup, a diary, or reminders have been or will be successful. That last clause is a return-visit instruction: somebody has to come back and find out whether the new support worked.

A dash is not valid on this item. Two edges are worth carrying in your head. A PRN oral medication that was needed on the day of assessment and required a reminder puts the item at Code 2; when no PRN was needed that day, assess on the medications scheduled for that day. And a patient living in a facility that holds or locks up medications is still scored on their own ability: whether they can get to where the medications are kept at the correct times and recognize and take the correct dose, recognizing that someone else has to make the medication available to them.

M2030 asks the same ability question about injectable medications, with a different task chain and a narrower scope. It excludes intravenous medications, infusions such as anything given by pump, and medications given in the physician's office or any setting outside the home, and it includes one-time injections administered in the home.

On top of obtaining and identifying the medication, the assessment covers drawing up the correct dose accurately using aseptic technique, injecting in an appropriate site using correct technique, and disposing of the syringe properly. When it is not time for a dose, ask the patient to describe and demonstrate the steps for administration and needle disposal and infer from that. The response ladder mirrors the oral item, with one addition: Code 3 also applies when the physician ordered the nurse to administer the injection in the home.

These answers are read by more than the chart. Appendix B flags the drug regimen review trio as quality items and flags the oral medication item as a quality item that also carries the value-based purchasing flag, and the manual describes agency quality partly in terms of a drug regimen review conducted with follow-up for identified issues. The HHVBP, Star Ratings, and QAPI section under Home Health Operations in Bonus Content covers how that scoring works, and the OASIS Item Codes and PDGM section covers where these codes sit inside the instrument. Neither is re-taught here.

The Errors That Cost the Most in Section N

Key takeaway

On a therapy only case the drug regimen review is yours, and the manual shows a PT doing it. The rest of Section N runs on definitions rather than impressions. A review is complete only when every element was assessed. An issue is clinically significant only when it warrants physician contact and a completed action by midnight of the next calendar day. Follow-up counts only when the loop closed and the action was done inside that window. An indication counts only when every medication in the class has one.